Hangjun Zhan
Director/Board Member presso Vetmab Biosciences, Inc.
Profilo
Hangjun Zhan is currently a Director at Vetmab Biosciences, Inc. He was previously the Chief Scientific Officer at Kindred Biosciences, Inc. from 2018 to 2021 and a Member at Aragen Bioscience, Inc. from 2010 to 2014.
Dr. Zhan has a graduate and doctorate degree from the University of Washington and an undergraduate degree from Zhejiang University, which he received in 1991.
Posizioni attive di Hangjun Zhan
| Società | Posizione | Inizio |
|---|---|---|
Vetmab Biosciences, Inc.
 Vetmab Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Vetmab Biosciences, Inc. is an American company that is developing life-changing therapeutics for pets. The company specializes in monoclonal antibodies (mabs) for modern veterinary practices. The CEO of the company is Denise Marie Bevers. | Director/Board Member | - |
Precedenti posizioni note di Hangjun Zhan
| Società | Posizione | Fine |
|---|---|---|
| KINDRED BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
Aragen Bioscience, Inc.
 Aragen Bioscience, Inc. BiotechnologyHealth Technology Aragen Bioscience, Inc. operates as a contract research organization focused on accelerating product development through science, professionalism and innovation. Its services include antibody discovery, protein science, efficacy testing, and cell line development. The company was founded by Rick Srigley in 1993 and is headquartered in Morgan Hill, CA. | Corporate Officer/Principal | 01/02/2014 |
Formazione di Hangjun Zhan
| University of Washington | Doctorate Degree |
| Zhejiang University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. | Health Technology |
Vetmab Biosciences, Inc.
Vetmab Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Vetmab Biosciences, Inc. is an American company that is developing life-changing therapeutics for pets. The company specializes in monoclonal antibodies (mabs) for modern veterinary practices. The CEO of the company is Denise Marie Bevers. | Commercial Services |
Aragen Bioscience, Inc.
Aragen Bioscience, Inc. BiotechnologyHealth Technology Aragen Bioscience, Inc. operates as a contract research organization focused on accelerating product development through science, professionalism and innovation. Its services include antibody discovery, protein science, efficacy testing, and cell line development. The company was founded by Rick Srigley in 1993 and is headquartered in Morgan Hill, CA. | Health Technology |
- Borsa valori
- Insiders
- Hangjun Zhan
